Valuation Novartis AG Mexican S.E.

Stocks

End-of-day quote Mexican S.E. Other stock markets 2026-06-18			5-day change	1st Jan Change
2,563.00 ^MXN	-1.46%		-1.46%	+2.52%

06-18	Swiss trade surplus at CHF 6.11 bln in May	RE
06-17	Medpace: At the Heart of the Small-Cap Biopharma Crisis

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	196,458	194,448	207,167	195,514	266,003	268,172	-	-
Change	-	-1.02%	6.54%	-5.62%	36.05%	0.82%	-	-
Enterprise Value (EV) ¹	204,649	203,482	219,178	213,458	289,870	300,432	296,470	290,310
Change	-	-0.57%	7.71%	-2.61%	35.8%	3.64%	-1.32%	-2.08%
P/E	8.2x	28.3x	14.1x	16.5x	19.2x	20.3x	17.4x	15.1x
PBR	2.9x	3.23x	4.41x	4.52x	5.73x	6.08x	5.64x	5.02x
PEG	-	-0.4x	0x	-1x	0.9x	115.52x	1x	1x
Capitalization / Revenue	3.81x	3.85x	4.44x	3.78x	4.69x	4.7x	4.44x	4.18x
EV / Revenue	3.96x	4.03x	4.7x	4.13x	5.11x	5.27x	4.91x	4.53x
EV / EBITDA	11.2x	10.9x	12.2x	10.2x	12.4x	12.8x	11.7x	10.5x
EV / EBIT	12.3x	12.2x	13.4x	10.9x	13.2x	14x	12.7x	11.5x
EV / FCF	15.4x	17x	16.6x	13.1x	16.5x	22.2x	18.3x	15.6x
FCF Yield	6.49%	5.87%	6.01%	7.61%	6.07%	4.5%	5.48%	6.42%
Dividend per Share ²	3.36	3.5	3.823	3.856	-	4.472	4.598	4.766
Rate of return	3.83%	3.87%	3.79%	3.94%	-	3.05%	3.14%	3.25%
EPS ²	10.71	3.19	7.15	5.92	7.21	7.223	8.434	9.689
Distribution rate	31.4%	110%	53.5%	65.1%	-	61.9%	54.5%	49.2%
Net sales ¹	51,626	50,545	46,660	51,722	56,674	57,018	60,425	64,153
EBITDA ¹	18,246	18,613	17,937	21,006	23,415	23,510	25,343	27,542
EBIT ¹	16,588	16,665	16,372	19,494	21,889	21,525	23,297	25,275
Net income ¹	24,021	6,955	14,854	11,939	13,967	14,148	15,672	17,555
Net Debt ¹	8,191	9,034	12,011	17,944	23,867	32,260	28,298	22,138
Reference price ²	87.82	90.40	100.79	97.79	138.63	146.50	146.50	146.50
Nbr of stocks (in thousands)	2,237,092	2,150,980	2,055,460	1,999,270	1,918,792	1,830,549	-	-
Announcement Date	2/2/22	2/1/23	1/31/24	1/31/25	2/4/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ELI LILLY AND COMPANY	32.01x	11.69x	23.99x	0.62%	980B
JOHNSON & JOHNSON	24.41x	5.63x	15.32x	2.34%	550B
ABBVIE INC.	26.86x	6.49x	13.28x	3.17%	382B
ROCHE HOLDING AG	17.04x	4.24x	10.43x	3.13%	316B
ASTRAZENECA PLC	21.94x	4.59x	13.02x	1.91%	272B
NOVO NORDISK A/S	13x	4.83x	9.94x	3.87%	199B
AMGEN INC.	21.95x	5.91x	10.33x	2.99%	182B
GILEAD SCIENCES, INC.	-44.34x	5.36x	29.54x	2.62%	154B
PFIZER INC.	11.79x	3.11x	7.57x	6.95%	144B
Average	13.85x	5.76x	14.82x	3.07%	353.09B
Weighted average by Cap.	21.35x	7.22x	16.78x	2.31%